Effects of a Wed-based FRAIL-SM Program Among Patients With Heart Failure

NCT ID: NCT07068308

Last Updated: 2025-07-25

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Clinical Phase

NA

Total Enrollment

328 participants

Study Classification

INTERVENTIONAL

Study Start Date

2026-01-01

Study Completion Date

2027-07-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study aims to examine the effects of web-based FRAIL-SM (Family involvement, self-Regulation skills training, Autonomy, Information sharing and Linkage, Self-Management) on frailty, self-management behaviors and quality of life in patients with heart failure and their families' heart failure knowledge, confidence, strain, and quality of life. Patients are recruited with a convenience sampling from two medical centers in Taiwan. The web-based FRAIL-SM includes Family involvement, self-Regulation, Autonomy support, Information sharing and Linkage.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

A randomized controlled trial is conducted. Subjects are selected using a convenience sampling and are randomly assigned to the intervention or control group by stratified randomization according to participation of post-acute care. Patients in the intervention group will receive an 8-week web-based FRAIL-SM program. Data is collected by researchers using a structural questionnaire including frailty, heart failure knowledge, self-care of heart failure, and quality of life and physical indicators such as levels of B-type natriuretic peptide, hemoglobin, hematocrit, albumin at baseline, 4 weeks, 8 weeks, 12 weeks and 24 weeks after enrollment.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Heart Failure

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

SINGLE

Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

wed-based FRAIL-SM program

Patients in the intervention group will receive an 8-week web-based FRAIL-SM program including family involvement, self-regulation, autonomy support, information sharing and linkage.

Group Type EXPERIMENTAL

web-based FRAIL-SM program

Intervention Type BEHAVIORAL

The 8-week web-based FRAIL-SM includes family involvement, self-regulation, autonomy support, information sharing and linkage.

control group

Patients in this group will receive usual care.

Group Type NO_INTERVENTION

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

web-based FRAIL-SM program

The 8-week web-based FRAIL-SM includes family involvement, self-regulation, autonomy support, information sharing and linkage.

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Aged above 20.
2. Diagnosed with heart failure or LVEF\<40%.
3. Clear consciousness, can communicate with Chinese and Taiwanese.
4. Consent to join in this study and have family partner.
5. Access to computer or smartphone
6. Meet one of the Study of Osteoporotic Fractures of frailty


1. Aged above 20.
2. Clear consciousness, can communicate with Chinese and Taiwanese.
3. Consent to join in this study and willing to accompany with patients.
4. Access to computer or smartphone

Exclusion Criteria

1. Bed-ridden or unable to perform activities of daily living independently.
2. Diagnosed with cognitive, psychiatric disease, or major depression.
3. Acute disease condition e.g. infection or thrombosis.
4. Contraindications of performing exercise such as uncontrolled hypertension, uncontrolled arrhythmia.
5. severe neurodegenerative or muscular diseases, e.g. parkinson's disease, arthritis.

Family criteria:


1. Bed-ridden or unable to perform activities of daily living independently.
2. Diagnosed with cognitive, psychiatric disease, or major depression.
3. Have employment relationship with patients
Minimum Eligible Age

20 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

National Yang Ming Chiao Tung University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

National Yang Ming Chiao Tung University

Taipei, , Taiwan

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Taiwan

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Ai-Fu Chiou, PhD

Role: CONTACT

886-2-28267354

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Ai-Fu Chiou Professor, PhD

Role: primary

886-2-28267354

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

NYCU113069AE

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Enhancing Heart Failure Self-Care
NCT00526773 COMPLETED NA